HEADER TRANSFERASE 07-MAY-22 7ZSO TITLE HUMAN PURINE NUCLEOSIDE PHOSPHORYLASE IN COMPLEX WITH JS-554 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PURINE NUCLEOSIDE PHOSPHORYLASE; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: PNP,INOSINE PHOSPHORYLASE,INOSINE-GUANOSINE PHOSPHORYLASE; COMPND 5 EC: 2.4.2.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PNP, NP; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PNP-INHIBITOR COMPLEX, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.DJUKIC,P.PACHL,P.REZACOVA REVDAT 4 07-FEB-24 7ZSO 1 REMARK REVDAT 3 07-JUN-23 7ZSO 1 JRNL REVDAT 2 24-MAY-23 7ZSO 1 JRNL REVDAT 1 17-MAY-23 7ZSO 0 JRNL AUTH J.SKACEL,S.DJUKIC,O.BASZCZYNSKI,F.KALCIC,T.BILEK, JRNL AUTH 2 K.CHALUPSKY,J.KOZAK,A.DVORAKOVA,E.TLOUST'OVA,Z.KRAL'OVA, JRNL AUTH 3 M.SMIDKOVA,J.VOLDRICH,M.RUMLOVA,P.PACHL,J.BRYNDA,T.VUCKOVA, JRNL AUTH 4 M.FABRY,J.SNASEL,I.PICHOVA,P.REZACOVA, JRNL AUTH 5 H.MERTLIKOVA-KAISEROVA,Z.JANEBA JRNL TITL DESIGN, SYNTHESIS, BIOLOGICAL EVALUATION, AND JRNL TITL 2 CRYSTALLOGRAPHIC STUDY OF NOVEL PURINE NUCLEOSIDE JRNL TITL 3 PHOSPHORYLASE INHIBITORS. JRNL REF J.MED.CHEM. V. 66 6652 2023 JRNL REFN ISSN 0022-2623 JRNL PMID 37134237 JRNL DOI 10.1021/ACS.JMEDCHEM.2C02097 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.81 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 3 NUMBER OF REFLECTIONS : 63905 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.217 REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.500 REMARK 3 FREE R VALUE TEST SET COUNT : 1639 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.00 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4496 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.31 REMARK 3 BIN R VALUE (WORKING SET) : 0.3390 REMARK 3 BIN FREE R VALUE SET COUNT : 115 REMARK 3 BIN FREE R VALUE : 0.2970 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6563 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 215 REMARK 3 SOLVENT ATOMS : 345 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.16 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : -0.04000 REMARK 3 B33 (A**2) : 0.04000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.192 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.173 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.156 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.044 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.912 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6929 ; 0.008 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 6369 ; 0.001 ; 0.015 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 9415 ; 1.515 ; 1.644 REMARK 3 BOND ANGLES OTHERS (DEGREES): 14596 ; 1.301 ; 1.575 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 849 ; 7.411 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 354 ;33.948 ;21.384 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1083 ;14.115 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 50 ;17.848 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 850 ; 0.067 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 7838 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1647 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 7ZSO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 09-MAY-22. REMARK 100 THE DEPOSITION ID IS D_1292122877. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-MAR-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 65544 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 200 DATA REDUNDANCY : 6.640 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.2900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 7ZSL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 500 MM AMMONIUM SULFATE; 1.00 M REMARK 280 LITHIUM SULFATE 100 MM; TRI-SODIUM CITRATE; PH 5.6, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.24000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 65.09000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 59.66500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 65.09000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.24000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 59.66500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 ALA A 288 REMARK 465 SER A 289 REMARK 465 MET B 1 REMARK 465 GLU B 2 REMARK 465 ASN B 3 REMARK 465 LYS B 287 REMARK 465 ALA B 288 REMARK 465 SER B 289 REMARK 465 MET C 1 REMARK 465 GLU C 2 REMARK 465 ASN C 3 REMARK 465 ASP C 286 REMARK 465 LYS C 287 REMARK 465 ALA C 288 REMARK 465 SER C 289 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 3 CG OD1 ND2 REMARK 470 GLU A 8 CG CD OE1 OE2 REMARK 470 LYS A 22 CG CD CE NZ REMARK 470 LYS A 123 CG CD CE NZ REMARK 470 LYS A 179 CG CD CE NZ REMARK 470 LYS A 287 CG CD CE NZ REMARK 470 ALA B 117 CB REMARK 470 GLN B 180 CG CD OE1 NE2 REMARK 470 GLN B 184 CG CD OE1 NE2 REMARK 470 ARG B 185 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 250 CG CD OE1 OE2 REMARK 470 GLU B 253 CG CD OE1 OE2 REMARK 470 LYS B 265 CG CD CE NZ REMARK 470 ASP B 286 CG OD1 OD2 REMARK 470 GLU C 8 CG CD OE1 OE2 REMARK 470 LYS C 22 CG CD CE NZ REMARK 470 LYS C 123 CG CD CE NZ REMARK 470 GLN C 180 CG CD OE1 NE2 REMARK 470 ARG C 185 CG CD NE CZ NH1 NH2 REMARK 470 GLU C 186 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 55 -11.54 78.94 REMARK 500 ALA A 65 125.46 -38.52 REMARK 500 THR A 221 -51.85 82.07 REMARK 500 ASN B 55 -4.49 72.85 REMARK 500 ALA B 65 105.47 -56.62 REMARK 500 PHE B 155 -61.11 -96.95 REMARK 500 GLN B 180 28.21 -75.87 REMARK 500 GLN B 184 -74.83 -62.08 REMARK 500 THR B 221 -58.03 84.03 REMARK 500 ASN B 243 145.38 -173.49 REMARK 500 SER B 251 133.05 -177.54 REMARK 500 GLN B 266 -90.24 -104.46 REMARK 500 SER C 33 129.92 -39.96 REMARK 500 ASN C 55 -1.25 64.57 REMARK 500 ASN C 137 76.76 -102.25 REMARK 500 GLN C 184 -60.68 -95.60 REMARK 500 ARG C 185 108.33 -49.20 REMARK 500 THR C 221 -56.75 83.82 REMARK 500 REMARK 500 REMARK: NULL DBREF 7ZSO A 1 289 UNP P00491 PNPH_HUMAN 1 289 DBREF 7ZSO B 1 289 UNP P00491 PNPH_HUMAN 1 289 DBREF 7ZSO C 1 289 UNP P00491 PNPH_HUMAN 1 289 SEQRES 1 A 289 MET GLU ASN GLY TYR THR TYR GLU ASP TYR LYS ASN THR SEQRES 2 A 289 ALA GLU TRP LEU LEU SER HIS THR LYS HIS ARG PRO GLN SEQRES 3 A 289 VAL ALA ILE ILE CYS GLY SER GLY LEU GLY GLY LEU THR SEQRES 4 A 289 ASP LYS LEU THR GLN ALA GLN ILE PHE ASP TYR GLY GLU SEQRES 5 A 289 ILE PRO ASN PHE PRO ARG SER THR VAL PRO GLY HIS ALA SEQRES 6 A 289 GLY ARG LEU VAL PHE GLY PHE LEU ASN GLY ARG ALA CYS SEQRES 7 A 289 VAL MET MET GLN GLY ARG PHE HIS MET TYR GLU GLY TYR SEQRES 8 A 289 PRO LEU TRP LYS VAL THR PHE PRO VAL ARG VAL PHE HIS SEQRES 9 A 289 LEU LEU GLY VAL ASP THR LEU VAL VAL THR ASN ALA ALA SEQRES 10 A 289 GLY GLY LEU ASN PRO LYS PHE GLU VAL GLY ASP ILE MET SEQRES 11 A 289 LEU ILE ARG ASP HIS ILE ASN LEU PRO GLY PHE SER GLY SEQRES 12 A 289 GLN ASN PRO LEU ARG GLY PRO ASN ASP GLU ARG PHE GLY SEQRES 13 A 289 ASP ARG PHE PRO ALA MET SER ASP ALA TYR ASP ARG THR SEQRES 14 A 289 MET ARG GLN ARG ALA LEU SER THR TRP LYS GLN MET GLY SEQRES 15 A 289 GLU GLN ARG GLU LEU GLN GLU GLY THR TYR VAL MET VAL SEQRES 16 A 289 ALA GLY PRO SER PHE GLU THR VAL ALA GLU CYS ARG VAL SEQRES 17 A 289 LEU GLN LYS LEU GLY ALA ASP ALA VAL GLY MET SER THR SEQRES 18 A 289 VAL PRO GLU VAL ILE VAL ALA ARG HIS CYS GLY LEU ARG SEQRES 19 A 289 VAL PHE GLY PHE SER LEU ILE THR ASN LYS VAL ILE MET SEQRES 20 A 289 ASP TYR GLU SER LEU GLU LYS ALA ASN HIS GLU GLU VAL SEQRES 21 A 289 LEU ALA ALA GLY LYS GLN ALA ALA GLN LYS LEU GLU GLN SEQRES 22 A 289 PHE VAL SER ILE LEU MET ALA SER ILE PRO LEU PRO ASP SEQRES 23 A 289 LYS ALA SER SEQRES 1 B 289 MET GLU ASN GLY TYR THR TYR GLU ASP TYR LYS ASN THR SEQRES 2 B 289 ALA GLU TRP LEU LEU SER HIS THR LYS HIS ARG PRO GLN SEQRES 3 B 289 VAL ALA ILE ILE CYS GLY SER GLY LEU GLY GLY LEU THR SEQRES 4 B 289 ASP LYS LEU THR GLN ALA GLN ILE PHE ASP TYR GLY GLU SEQRES 5 B 289 ILE PRO ASN PHE PRO ARG SER THR VAL PRO GLY HIS ALA SEQRES 6 B 289 GLY ARG LEU VAL PHE GLY PHE LEU ASN GLY ARG ALA CYS SEQRES 7 B 289 VAL MET MET GLN GLY ARG PHE HIS MET TYR GLU GLY TYR SEQRES 8 B 289 PRO LEU TRP LYS VAL THR PHE PRO VAL ARG VAL PHE HIS SEQRES 9 B 289 LEU LEU GLY VAL ASP THR LEU VAL VAL THR ASN ALA ALA SEQRES 10 B 289 GLY GLY LEU ASN PRO LYS PHE GLU VAL GLY ASP ILE MET SEQRES 11 B 289 LEU ILE ARG ASP HIS ILE ASN LEU PRO GLY PHE SER GLY SEQRES 12 B 289 GLN ASN PRO LEU ARG GLY PRO ASN ASP GLU ARG PHE GLY SEQRES 13 B 289 ASP ARG PHE PRO ALA MET SER ASP ALA TYR ASP ARG THR SEQRES 14 B 289 MET ARG GLN ARG ALA LEU SER THR TRP LYS GLN MET GLY SEQRES 15 B 289 GLU GLN ARG GLU LEU GLN GLU GLY THR TYR VAL MET VAL SEQRES 16 B 289 ALA GLY PRO SER PHE GLU THR VAL ALA GLU CYS ARG VAL SEQRES 17 B 289 LEU GLN LYS LEU GLY ALA ASP ALA VAL GLY MET SER THR SEQRES 18 B 289 VAL PRO GLU VAL ILE VAL ALA ARG HIS CYS GLY LEU ARG SEQRES 19 B 289 VAL PHE GLY PHE SER LEU ILE THR ASN LYS VAL ILE MET SEQRES 20 B 289 ASP TYR GLU SER LEU GLU LYS ALA ASN HIS GLU GLU VAL SEQRES 21 B 289 LEU ALA ALA GLY LYS GLN ALA ALA GLN LYS LEU GLU GLN SEQRES 22 B 289 PHE VAL SER ILE LEU MET ALA SER ILE PRO LEU PRO ASP SEQRES 23 B 289 LYS ALA SER SEQRES 1 C 289 MET GLU ASN GLY TYR THR TYR GLU ASP TYR LYS ASN THR SEQRES 2 C 289 ALA GLU TRP LEU LEU SER HIS THR LYS HIS ARG PRO GLN SEQRES 3 C 289 VAL ALA ILE ILE CYS GLY SER GLY LEU GLY GLY LEU THR SEQRES 4 C 289 ASP LYS LEU THR GLN ALA GLN ILE PHE ASP TYR GLY GLU SEQRES 5 C 289 ILE PRO ASN PHE PRO ARG SER THR VAL PRO GLY HIS ALA SEQRES 6 C 289 GLY ARG LEU VAL PHE GLY PHE LEU ASN GLY ARG ALA CYS SEQRES 7 C 289 VAL MET MET GLN GLY ARG PHE HIS MET TYR GLU GLY TYR SEQRES 8 C 289 PRO LEU TRP LYS VAL THR PHE PRO VAL ARG VAL PHE HIS SEQRES 9 C 289 LEU LEU GLY VAL ASP THR LEU VAL VAL THR ASN ALA ALA SEQRES 10 C 289 GLY GLY LEU ASN PRO LYS PHE GLU VAL GLY ASP ILE MET SEQRES 11 C 289 LEU ILE ARG ASP HIS ILE ASN LEU PRO GLY PHE SER GLY SEQRES 12 C 289 GLN ASN PRO LEU ARG GLY PRO ASN ASP GLU ARG PHE GLY SEQRES 13 C 289 ASP ARG PHE PRO ALA MET SER ASP ALA TYR ASP ARG THR SEQRES 14 C 289 MET ARG GLN ARG ALA LEU SER THR TRP LYS GLN MET GLY SEQRES 15 C 289 GLU GLN ARG GLU LEU GLN GLU GLY THR TYR VAL MET VAL SEQRES 16 C 289 ALA GLY PRO SER PHE GLU THR VAL ALA GLU CYS ARG VAL SEQRES 17 C 289 LEU GLN LYS LEU GLY ALA ASP ALA VAL GLY MET SER THR SEQRES 18 C 289 VAL PRO GLU VAL ILE VAL ALA ARG HIS CYS GLY LEU ARG SEQRES 19 C 289 VAL PHE GLY PHE SER LEU ILE THR ASN LYS VAL ILE MET SEQRES 20 C 289 ASP TYR GLU SER LEU GLU LYS ALA ASN HIS GLU GLU VAL SEQRES 21 C 289 LEU ALA ALA GLY LYS GLN ALA ALA GLN LYS LEU GLU GLN SEQRES 22 C 289 PHE VAL SER ILE LEU MET ALA SER ILE PRO LEU PRO ASP SEQRES 23 C 289 LYS ALA SER HET JTC A 301 35 HET GOL A 302 6 HET GOL A 303 6 HET SO4 A 304 5 HET SO4 A 305 5 HET SO4 A 306 5 HET SO4 A 307 5 HET SO4 A 308 5 HET SO4 A 309 5 HET SO4 A 310 5 HET NA A 311 1 HET JTC B 301 35 HET SO4 B 302 5 HET SO4 B 303 5 HET SO4 B 304 5 HET JTC C 301 35 HET GOL C 302 6 HET SO4 C 303 5 HET SO4 C 304 5 HET SO4 C 305 5 HET SO4 C 306 5 HET SO4 C 307 5 HET SO4 C 308 5 HET SO4 C 309 5 HET SO4 C 310 5 HET NA C 311 1 HETNAM JTC [(~{E})-2-[2-[(4-OXIDANYLIDENE-3,5-DIHYDROPYRROLO[3,2- HETNAM 2 JTC D]PYRIMIDIN-7-YL)SULFANYL]-5-[2,3,4,5,6- HETNAM 3 JTC PENTAKIS(FLUORANYL)PHENOXY]PHENYL]ETHENYL]PHOSPHONIC HETNAM 4 JTC ACID HETNAM GOL GLYCEROL HETNAM SO4 SULFATE ION HETNAM NA SODIUM ION HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 4 JTC 3(C20 H11 F5 N3 O5 P S) FORMUL 5 GOL 3(C3 H8 O3) FORMUL 7 SO4 18(O4 S 2-) FORMUL 14 NA 2(NA 1+) FORMUL 30 HOH *345(H2 O) HELIX 1 AA1 THR A 6 THR A 21 1 16 HELIX 2 AA2 LEU A 35 LEU A 42 5 8 HELIX 3 AA3 GLY A 51 ILE A 53 5 3 HELIX 4 AA4 HIS A 86 GLY A 90 5 5 HELIX 5 AA5 PRO A 92 THR A 97 1 6 HELIX 6 AA6 THR A 97 LEU A 106 1 10 HELIX 7 AA7 LEU A 138 SER A 142 1 5 HELIX 8 AA8 ASP A 167 MET A 181 1 15 HELIX 9 AA9 THR A 202 LEU A 212 1 11 HELIX 10 AB1 THR A 221 GLY A 232 1 12 HELIX 11 AB2 ASN A 256 ALA A 280 1 25 HELIX 12 AB3 THR B 6 SER B 19 1 14 HELIX 13 AB4 LEU B 35 LEU B 42 5 8 HELIX 14 AB5 GLY B 51 ILE B 53 5 3 HELIX 15 AB6 HIS B 86 GLY B 90 5 5 HELIX 16 AB7 PRO B 92 THR B 97 1 6 HELIX 17 AB8 THR B 97 GLY B 107 1 11 HELIX 18 AB9 LEU B 138 SER B 142 1 5 HELIX 19 AC1 ASP B 167 GLN B 180 1 14 HELIX 20 AC2 THR B 202 LEU B 212 1 11 HELIX 21 AC3 THR B 221 CYS B 231 1 11 HELIX 22 AC4 ASN B 256 GLY B 264 1 9 HELIX 23 AC5 ALA B 267 MET B 279 1 13 HELIX 24 AC6 ALA B 280 ILE B 282 5 3 HELIX 25 AC7 THR C 6 THR C 21 1 16 HELIX 26 AC8 LEU C 35 LEU C 42 5 8 HELIX 27 AC9 GLY C 51 ILE C 53 5 3 HELIX 28 AD1 HIS C 86 GLY C 90 5 5 HELIX 29 AD2 PRO C 92 THR C 97 1 6 HELIX 30 AD3 THR C 97 LEU C 106 1 10 HELIX 31 AD4 LEU C 138 SER C 142 1 5 HELIX 32 AD5 ASP C 167 MET C 181 1 15 HELIX 33 AD6 THR C 202 LEU C 212 1 11 HELIX 34 AD7 THR C 221 CYS C 231 1 11 HELIX 35 AD8 ASN C 256 MET C 279 1 24 HELIX 36 AD9 ALA C 280 ILE C 282 5 3 SHEET 1 AA110 THR A 43 ASP A 49 0 SHEET 2 AA110 ARG A 67 LEU A 73 -1 O LEU A 68 N PHE A 48 SHEET 3 AA110 ARG A 76 MET A 81 -1 O CYS A 78 N GLY A 71 SHEET 4 AA110 VAL A 27 ILE A 30 1 N ILE A 29 O VAL A 79 SHEET 5 AA110 THR A 110 GLY A 119 1 O VAL A 112 N ALA A 28 SHEET 6 AA110 ARG A 234 LYS A 244 1 O ARG A 234 N LEU A 111 SHEET 7 AA110 ILE A 129 ASN A 137 -1 N MET A 130 O SER A 239 SHEET 8 AA110 GLN A 188 MET A 194 1 O GLN A 188 N ILE A 129 SHEET 9 AA110 ALA A 216 GLY A 218 1 O ALA A 216 N VAL A 193 SHEET 10 AA110 THR A 110 GLY A 119 -1 N GLY A 118 O VAL A 217 SHEET 1 AA210 THR B 43 ASP B 49 0 SHEET 2 AA210 ARG B 67 LEU B 73 -1 O LEU B 68 N PHE B 48 SHEET 3 AA210 ARG B 76 GLN B 82 -1 O CYS B 78 N GLY B 71 SHEET 4 AA210 VAL B 27 CYS B 31 1 N CYS B 31 O MET B 81 SHEET 5 AA210 THR B 110 GLY B 119 1 O THR B 110 N ALA B 28 SHEET 6 AA210 ARG B 234 LYS B 244 1 O ASN B 243 N GLY B 119 SHEET 7 AA210 ILE B 129 ASN B 137 -1 N MET B 130 O SER B 239 SHEET 8 AA210 GLN B 188 MET B 194 1 O GLN B 188 N LEU B 131 SHEET 9 AA210 ALA B 216 GLY B 218 1 O ALA B 216 N VAL B 193 SHEET 10 AA210 THR B 110 GLY B 119 -1 N GLY B 118 O VAL B 217 SHEET 1 AA310 THR C 43 ASP C 49 0 SHEET 2 AA310 ARG C 67 LEU C 73 -1 O LEU C 68 N PHE C 48 SHEET 3 AA310 ARG C 76 GLN C 82 -1 O CYS C 78 N GLY C 71 SHEET 4 AA310 VAL C 27 ILE C 30 1 N ILE C 29 O VAL C 79 SHEET 5 AA310 THR C 110 GLY C 119 1 O VAL C 112 N ALA C 28 SHEET 6 AA310 ARG C 234 LYS C 244 1 O ARG C 234 N LEU C 111 SHEET 7 AA310 ILE C 129 ASN C 137 -1 N MET C 130 O SER C 239 SHEET 8 AA310 GLN C 188 MET C 194 1 O GLN C 188 N LEU C 131 SHEET 9 AA310 ALA C 216 GLY C 218 1 O ALA C 216 N VAL C 193 SHEET 10 AA310 THR C 110 GLY C 119 -1 N GLY C 118 O VAL C 217 LINK NA NA A 311 O2 SO4 B 303 1555 1555 2.26 LINK O2 SO4 C 306 NA NA C 311 1555 1555 3.01 CISPEP 1 GLY A 197 PRO A 198 0 5.98 CISPEP 2 GLY B 197 PRO B 198 0 5.38 CISPEP 3 GLY C 197 PRO C 198 0 8.76 CRYST1 58.480 119.330 130.180 90.00 90.00 90.00 P 21 21 21 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017100 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008380 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007682 0.00000